Phase i safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
- Soria, J.-C.
- Cortes, J.
- Massard, C.
- Armand, J.-P.
- De andreis, D.
- Ropert, S.
- Lopez, E.
- Catteau, A.
- James, J.
- Marier, J.-F.
- Beliveau, M.
- Martell, R.E.
- Baselga, J.
ISSN: 1569-8041, 0923-7534
Datum der Publikation: 2012
Ausgabe: 23
Nummer: 2
Seiten: 463-471
Art: Artikel